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Suppressor cells assayed by numerical and functional tests in chronic
renal failure. Suppressor cells were assayed by numerical and function-
al tests in adults on chronic hemodialysis. Peripheral blood mononucle-
ars (PBM) were classified as total T-cells by E-rosettes and by the
monoclonal antibody OKT3, as T-cell subsets by OKT4 (inducer/helper
T-cells) and OKT8 (cytotoxic/suppressor T-cells) and as B-cells by the
presence of surface immunoglobulin. The suppressive effect of PBM
pretreated with either Concanavalin A (Con A), sodium periodate, or
serum rich in immune complexes, on normal homologous phytohemag-
glutinin (PHA) lymphocyte transformation, was determined. Usual
tests of 'f-cell function were not done. T lymphopenia was due to
significant diminution (P <0.002) in numbers of OKT4 cells in patients
(516 44 cells/mm3, mean sEM) as compared to controls (906 96
cells/mm3). fhe number of OKT5 cells in patients was not different
from normal although their percentage (45 4%) was slightly higher
than controls (36 5%) (P < 0.10). Suppressor activity using only a
suboptimal dose of Con A (5 rg/ml), was significantly lower (P < 0.002)
in uremic patients (36 12%) than in controls (67 7%). An important
finding was that no significant correlations were detected between the
numerical and functional assays of suppression used or between any of
these immunological tests and biochemical parameters studied. The
implications of these results for immunoparesis in uremia are discussed
with particular reference to the discordance between marker and
functional assays of suppressor cells.
Cellules suppressives mesurées par des tests numériques et fonctionnels
dans l'insuffisance rénaie chronique. Les cellules suppressives ont été
étudiées par des tests numériques et fonctionnels chez des adultes en
hemodialyse chronique. Les mononucléaires sanguins périphériqucs(PBM) ont été classes en cellules F totales par les rosettes E, et par
l'anticorps monoclonal OKT3 et en sous-populations de cellules T par
OKT4 (cellules T encouragement/aide) et par OKT8 (cellules T cytotox-
iques/suppressives) et en cellules B par Ia presence d'immunoglobulines
de surface. L'effet suppressif des PBM prétraités avec de Ia Concanava-
lin A (Con A), du pCriodale de sodium, ou un serum riche en inimuns
complexes, sur Ia transformation lymphocytaire norinale homologue a
Ia phytohemagglutinin (PHA) a Cté dCtcrminC. Lcs tests habituels de Ia
fonction des cellules T n'ont pas etC faits. l.a lymphopénie T était due a
une dimunition significative (P < 0,002) du nombre de cellules OKT4
chez les malades (516 44 cellulcs/mm3, rnoyenne SEM) par rapport
aux contrôles (906 96 cellules/mm3). Le noinbre de ccllulcs OKT5
chez les malades ne difi'Crait pas des normaux hien que leur pourcentage
(45 4%) soit legerement plus élevé que chez les contrbles (36 6%)
(P < 0,10). L'activitC suppressive en utilisant seulement des doses
sous-optimales de Con A (5 sg/ml) était significativement plus faible (P
<0,002) chez es malades urémiques (36 12%) que chez les contrOles
(67 7%). Un résultat important est qu'aucunc correlation significative
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n'a Cté trouvCe entre les mesures numériques et fonctionnelles, ou entre
aucun de ces tests immunologiques el les parametres biochimiques
CtudiCs. Les implications de ces rCsultats dans l'immunoparesie de
l'urCmie sont discutées en se rCfCrant particuliCrement a Ia discordance
entre les mesures avec des marqueurs et les mesures fonctionnelles des
cellules suppressives.
Uremia is known to be immunosuppressive [1—8] and the
clinical relevance of this is seen in the high incidence of
infections and neoplasia [9] recorded in these patients. The
mechanisms responsible for this relative anergy are unknown
and have been ascribed to many factors including unspecified
uremic toxins and malnutrition.
Normal immune homeostasis is probably due to a delicate
balance between positive and negative influences from inducer
and suppressor T-cell suhpopulations within the human T-cell
circuit [10]. It follows, therefore, that imbalances in these
control mechanisms might lead to disease. Abnormalities of
suppressor cell function, in fact, have been described in man,
for example, depressed suppressor function in systemic lupus
erythematosus [11] and accentuated suppressor activity in
hypogammaglobulinemia [12].
Impaired cell mediated immunity in uremic rats accompanied
by increased activity of suppressor cells [13] and of T-cell
depletion associated with retention or even augmentation of
suppressor cell activity in renal failure patients on hemodialysis
[14] suggest an important role for immunoregulatory cells in this
disease. Discordant results between different functional assays
of suppression in autoimmune disease [15] indicate that there is
at present no single satisfactory test to measure this component
of the immune response. These facts prompted us to compare
several functional suppressor cell assays and attempt to corre-
late these with numerical estimates of T-ceIl subsets using
specific murine monoclonal antibody in a further attempt to
elucidate the immunodeficiency in uremia. Conventional tests
of 'f-cell function such as delayed hypersensitivity, cytotoxic-
ity, help and suppression of immunoglobulin synthesis were not
performed. As the uremic state is characterized by wide fluctu-
ations in biochemical indices, and as some of these have been
shown to have adverse effects on the immune response [16], we
also assessed the influence of serum levels of selected metals
and nutrients on the tests of immunity studied in these patients.
Methods
Patients and controls. Nineteen patients undergoing regular
hemodialysis (4 to 5.5 hr, three times a week), at the Addington
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2 33 M W
3 29 M I
4 58 M W
5 31 M I
6 40 M I
7 52 M I
8 17 M I
9 49 M W
10 28 F I
11 22 F W
12 54 M W
13 47 M W
14 15 M I
15 22 M W
16 63 M W
17 18 F I
18 21 F I





No Chronic pyelonephritis due to vesico-ureteric reflux
Yes Chronic glomerulonephritis (renal biopsy)
No Membrano-proliferative glomerulonephritis (renal
biopsy)
No Analgesic nephropathy




No Hypernephroma/Focal proliferative glomerulonephri-
tis (renal biopsy)
No Systemic lupus erythematosis
No Chronic glomerulonephritis




Yes Rapidly progressive glomerulonephritis (renal biopsy)
Yes Chronic pyelonephritis and ureteric valves (renal
biopsy)
Yes Chronic glomerulonephritis (renal biopsy)
Yes Malignant hypertension
No Analgesic nephropathy
Abbreviations: 1, Indian South African; W, White South African.
Hospital, Durban, were studied (Table 1). They ranged in age
from 15 to 63 years (mean, 35 years). There were ten white and
nine Indian patients; 14 were male. Chronic renal failure was
ascribed to chronic glomerulonephritis in six patients and
analgesic nephropathy in four. Chronic pyelonephritis, malig-
nant hypertension, and Alport syndrome accounted for two
patients, while the remaining three patients had crescentic
nephritis, systemic lupus erythematosus, and polycystic kidney
disease. The patient with crescentic nephritis was on daily oral
doses of 20 mg prednisolone and 150 mg cyclophosphamide.
One patient with chronic glomerulonephritis had been success-
fully treated surgically for a hypernephroma, diagnosed at the
time of presentation with chronic renal failure.
All blood samples were taken prior to hemodialysis and
immediately before systemic heparinization. As patients were
lymphopenic, all the tests discussed below could not be done on
every individual. The exact number studied is given in the
tables.
The patients were age-, sex-, and race-matched with 19
normal healthy volunteers.
Materials. In all cases peripheral blood mononuclear cells
were separated from heparinized blood using the Ficoll-Hy-
paque density gradient as described by Boyum [171.
AB serum refers to cytotoxic antibody free, red blood cell
free, homologous AB serum which had been heat-inactivated at
56° C for 30 mm. Culture medium used was Eagle's minimal
essential medium with Heppes buffer (pH 7.3), containing
penicillin, 100 U, and streptomycin, 100 g, per milliliter of
medium.
Monoclonal antibodies to various T-cell antigens. These
were purchased from ORTHO Pharmaceutical Corporation,
Immunobiology Division, Raritan, New Jersey, where they
were produced by mouse hybridomas [181. In this study the
antibodies OKT3 reacting with all peripheral blood T-cells,
OKT4 with T-cells having helper/inducer function, and OKT8
with T-cells displaying cytotoxic/suppressor function were used
[19, 201.
Fluorescein-isothiocyanate conjugates (FITC). (1) FITC anti-
human globulin serum was obtained from Burroughs Wellcome
(MFOI). (2) FITC goat anti-mouse lgG2 antibody (FITC-GAM)
was purchased from Meloy Laboratories, Inc., Diagnostic
Division, Springfield, Virginia, and used in a dilution of 1:30 of
the stock solution in phosphate-buffered saline (pH 7.2).
Mitogens. These mitogens included: (1) Concanavalin A (250
mg), Calbiochem, San Diego, California; (2) phytohemaggluti-
nm (2 mg), Phaseolus Supply, Burroughs Wellcome; (3) sodium
periodate (100 g) (Na104) 213.89, BDH Chemicals Ltd., Poole,
England.
Drugs. Mitomycin C (2 mg) was used [Streptomycies Caespi-
tosus, Pharmafrica (Pty.) Ltd., Hillbrow, Johannesburgi.
Other materials included: cell harvester, multiple automated
sample harvester and microtitre plates, Titertek round bottom
plates with sterile lids.
Numerical assays
Lymphocyte subpopulations identified by sheep red-blood
cell (E) rosettes and by surftice immunoglohulin (SIg). Subpop-
ulations of lymphocytes were enumerated in a single prepara-
tion using E-rosette formation, together with direct immunoflu-
orescence of Sig with FITC anti-human globulin serum, using a
technique described by Brain, Gordon, and Willetts and Brain
et al [21, 221. Peripheral blood lymphocytes were classified as
rosetting cells (E-rosettes), fluorescing cells (SIg), and cells
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Lymphocyte subpopulations identified by murine monoclonal
antibodies. For each specimen examined, three Nunc plastic
cell culture test tubes, each containing 0.2 ml of peripheral
blood mononuclear cells (PBM) at a concentration of 5 X 106
cells per milliliter of culture medium plus 5% AB serum, mixed
with 5pJ of one of the monoclonal antibodies, OKT3, OKT4, or
OKT8 were incubated at 00 C for 30 mm. The cells then were
washed twice in 2 ml of culture medium, plus 5% AB serum at
40 C, centrifuging each time for 10 mm in the cold. After the
second wash, the cell pellet was resuspended in 0.1 ml of
culture medium plus 5% AB serum (as above) and mixed with
0.1 ml of FITC-GAM previously diluted to 1:30, and then
incubated for 30 mm at 00 C. The cells were then washed twice
as described above, after which the cell pellet was resuspended
in one drop of 30% v/v glycerol in phosphate-buffered saline
(pH 7.2) and immediately placed on a glass slide and examined
under ultraviolet light, using a Leitz Orthoplan microscope.
Each specimen was examined in duplicate by two independent
observers who counted the number of fluorescing cells from a
total 200 cells.
The results were expressed in the following way: (1) Absolute
numbers of cells displaying fluorescence with OKT3, OKT4,
OKT8, respectively, were derived from the total absolute
mononuclear count (lymphocytes + monocytes) of the same
specimen estimated from a differential count of the peripheral
white cell number obtained from the Coulter counter. (2) The
OKT4 and OKT8 positive subsets were expressed as percentages
of the OKT3 subset. (3) The ratio of the OKT4/OKT8 positive
subsets was calculated.
Functional assays of suppression
Con A induction of suppressor cells to normal PHA transfor-
mation of lymphocytes. This method is derived from that
described by Shou, Schwartz and Good [23]. (1) Induction of
suppressor cells with Con A. PBM were suspended in Nunc
plastic cell culture test tubes in culture medium plus 15% AB
serum at a concentration of 2 x 106 cells/mI and cultured for 48
hr at 370 C in the presence or absence of Con A at two different
concentrations of 30 jsg/ml and 5 tg/ml of cells—these were
shown previously to produce optimal and suboptimal stimula-
tion, respectively, of suppressor activity. The cells then were
treated with Mitomycin C, 40 g per 10 x 106 cells/mI for 30 mm
at 37° C, washed three times, and resuspended in culture
medium plus 15% AB serum at a concentration of 1.33 X l0
cells/mi.
(2) Assay of suppressor activity on PHA transformation of
normal responder lymphocytes. Normal PBM from a single
donor were stored in 5 X l0 cells/mi aliquots in culture medium
plus 10% AB serum and 10% dimethyl sulfoxide in liquid
nitrogen, and were used as responder cells at 1.33 x l0 cells/mI
culture medium + 15% AB serum to stimulation by Phytohe-
magglutinin 0.4 jsg/25 sI for all experiments. The effect of
patient cells, both Con A stimulated and nonstimulated, on the
transformation of normal responder lymphocytes, was mea-
sured by incorporation of '4C-thymidine after a 72-hr incuba-
tion. Experiments were done in triplicate in microtiter plates,
each well of which contained 75 d of responder cells, 75 p1 of
either Con A and mitomycin C-treated or untreated cells under
test, 25 p1 of PHA, and 25 p1 of AB serum. Cells were harvested
on glass-fiber paper discs using a cell harvester and dried in a
37° C incubator for at least 2 hr. Samples were placed in
individual glass vials containing 2 ml Instagel scintillation fluid.
The thymidine uptake was counted in a Packard liquid scintilla-
tion counter.
The percentage suppression of mitogen response was calcu-
lated as follows:
I DPM Con A-stimulated cells% Con A suppression = 1 — __________________________DPM non-stimulated cells
x 100
DPM DPM of PHA-stimulated cells — DPM cells without
PHA.
Na104 induction of suppressor cells to normal PHA transfor-
mation of lymphocytes. Na104 is not as well established as Con
A as a suppressor cell activator. It has been suggested that
different membrane sites are involved in lymphocyte transfor-
mation by Na104 and Con A. The periodate target site seems to
include a glycoprotein complex containing sialic acid, the
oxidation of which yields aldehyde groups necessary for trans-
formation [24]. Na104 requires a short incubation time to
produce its effect and this can be eliminated completely by
glucose present in the culture medium.
(I) Induction of suppressor cells with Na104. This method is
adapted from that described by Galanaud et al [25]: PBM were
suspended in Nunc plastic cell culture tubes at a concentration
of 5 x 106 cells/ml in phosphate-buffered saline (pH 7.2) with
and without the addition of 2 mmoles Na104 and left at room
temperature 23° C for 10 mm. Two millimoles of Na104 had
been found previously to stimulate maximal suppressor activi-
ty. The PBM were then washed three times in culture medium
to remove and inactivate the Na104, the cells were then
resuspended at 2 x 106 cells/mi in culture medium and 15% AB
serum, and incubated for 48 hr at 37° C, followed by treatment
with mitomycin C and resuspended in culture medium + 15%
AB serum at a concentration of 1.33 cells x 106/ml.
(2) Assay of suppressor activity on PHA transformation of
normal responder lymphocytes. This assay was identical to that
described above for Con A.
Circulating immune complex induction of suppression of the
normal PHA response. Circulating immune complexes have
been demonstrated to enhance and suppress humoral and
cellular immune responses. The suppressor effect predominant-
ly studied in animals has been attributed to several mechanisms
including possible B-cell-mediated suppression [26] contrasting
with previously described possible suppression by T-cell sub-
sets [27].
In this experiment, plasma was used which had been obtained
from a patient with systemic lupus erythematosus, demonstrat-
ed to have high levels of circulating immune complexes by the
Raji cell assay, and which had been stored at 2O° C.
The method adopted was identical to that described above for
Con A except that 25 p1 of this undiluted plasma preparation
was substituted for the Con A to induce suppressor cells.
Biochemical investigations. The following routine biochemi-
cal and hematological tests were done using standard tech-
niques at the same time as the immunological assays on the
peripheral blood of the uremic patients: urea and electrolytes,
creatinine, calcium, phosphate, alkaline phosphatase, magne-
sium, uric acid, folic acid, serum iron and total iron binding
capacity, triglycerides t cholesterol, albumin, globulin, hemo-
All patients 1405 b 222 31
146
— (4 0.50)
1606 1196 131 226 37 154 18
153
Abbreviation: ND, not done.
a Absolute number (%).
b Mean SEM.
For absolute numbers except columns II and 12.
(80 2) (15 2) (9 0.80)
globin, and white cell count. In addition, plasma zinc levels
were estimated by atomic absorption [28].
Measurement of nutritional status. This was assessed by
measurements of weight and height and by estimates of mid-
arm muscle circumference calculated from the mid-arm circum-
ference and skin fold thickness, using a Harpenden skin-fold
caliper [29].
Results
Patient details are given in Table 1.
Statistical analysis. Results were analyzed using the non-
parametric Mann-Whitney U test. The computed U statistic
was tested at a 5% level of significance. Correlation analysis
was performed by testing the linear correlation co-efficient at a
5% level of significance.
Nutritional indices. The hemodialysis patients were found to
have an adequate level of nutrition. None had a serum albumin
level below 30 g/liter; only two had serum folate levels below 5
.tg!ml and percentage transferrin saturation less than 15%, and
three out of 14 patients who had estimations of mid-arm muscle
circumference had results below 80% of the standard [29].
Numerical assays. The results of these assays are set out in
Table 2. The patients with uremia had a significant absolute
lymphopenia of total PBM as well as a T-cell lymphopenia as
measured both by the E-rosette technique and the monoclonal
antibody OKT3. There was significant positive correlation
between the total T-cell population measured by these two
techniques in both the normal controls (sample correlation co-
efficient R = 0.745 a = 0.001) and in the patients with chronic
renal failure (R = 0.917 a = 0.01).
The OKT3 population was consistently smaller than the E-
rosette population in the controls. OKT3 and E-rosette cells
formed 49 and 74%, respectively, of the total absolute mononu-
clear count. The OKT3 cells amounted to 67.0% of the E-rosette
subset in the controls. Similarly, in the patients, OKT3 cells
accounted for 44% and E-rosette cells for 74% of the total
mononuclear count.
Paralleling the T-cell lymphopenia, there was an absolute B-
cell (SIg) lymphopenia in the patients, while there was no
difference in the Null cell counts between the patients and
controls. The absolute number of OKT4 cells in the patients
was significantly lower than the controls, but when these results
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Table 2. Subpopulations of peripheral blood lymphocytes identified by E-rosettes, Sig, and monoclonal antibodies (OKT3, OKT4, OKT8) in pa-
tients on chronic hemodialysis and in controls
Total
lympho- Total
Patient no. cytes monocytes
Mononuclear cells in Mononuclear cells defined by E- T-cell subsets as defined by
peripheral blood smear rosettes and surface Ig specific monoclonal antibodies
Total
mono-
nuclear T cells (E-
cells rosette)
B cells
(S1g) Null cells OKT1
1 2825 0 2825 1977(70) 565(20) 285(10) 1214(43)
2 1500 450(6)a 1950 1462(75) 292(15) 176(9) 1073(55)
3 1600 80(1) 1680 1360(81) 235(14) 68(4) 823(49)
4 880 264(3) 1144 915(80) 92(8) 114(/0) 400(35)
5 2560 192(3) 2752 2202(80) 303(/1) 248(9) 1101(40)
6 322 46(2) 368 ND ND ND 150(41)
7 1716 220(5) 1936 1258(65) 484(25) 194(10) 774(40)
8 670 0 670 563(84) 54(8) 53(8) 355(53)
9 1944 378(7) 2322 1927(83) 186(8) 209(9) 975(42)
10 2106 270(5) 2376 2091(88) 214(9) 71(3) 1212(5/)
11 1020 0 1020 857(84) 82(8) 71(7) 469(46)
12 1207 213(3) 1420 944(70) 185(13) 199(14) 710(50)
13 770 275(5) 1045 878(84) 115(11) 52(5) 449(43)
14 1005 268(4) 1273 891(70) 255(20) 127(10) 560(44)
15 1407 0 1407 1041(74) 197(/4) 169(12) 475(34)
16 1173 0 1173 891(76) 176(15) 94(8) 738(63)
17 1242 184(4) 1426 913(64) 343(24) 171(12) 699(49)
18 1804 44(1) 1848 1164(63) 517(28) 166(9) 813(44)
19 1650 220(2) 1870 1085(58) 486(26) 299(16) 542(29)
Positive cells as %
of OKT3 Ratio
- - OKT4/
OKT4 OKT8 OKT4 OKT8 OKT8
757(27) 805(28) 62 66 0.94
410(21) 546(28) 38 50 0.75
638(38) 218(/3) 78 26 3.00
389(34) 137(/2) 97 34 2.85
798(29) 716(26) 72 65 1.10
63(17) 81(22) 42 54 0.77
426(22) 407(21) 55 53 1.03
328(49) 73(//) 92 21 4.49
743(32) 743(32) 76 76 1.00
570(24) 760(32) 47 63 0.74
389(38) 183(/8) 83 39 2.12
454(32) 412(29) 64 58 1.10
314(30) 188(/8) 70 42 1.66
547(43) 242(/9) 98 43 2.27
427(30) 240(/7) 90 51 1.78
689(59) 177(/5) 93 24 3.89
713(50) 161(//) 102 23 4.43
425(23) 129(7) 52 16 3.25
729(39) 299(/6) 135 55 2.45
— — 2.08±
0.28





712 70 516 44 343 57
(45 2) (34 3) (20 2) (76 6) (45 4)
< 0.002 > 0.10 < 0.002 < 0.002 < 0.002 > 0.10
1915 182 498 45 121 14 1275 145 906 96 426 58 — 2.97
0.40
(75 2) (IS 2) (9 0.80) (46 2) (34 3) (20 2) (83 9) (36 5) —
< 0.02 < 0.002 > 0.10 > 0.10 > 0.05 > 0.10
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Table 3. Assays of suppressor cell function in patients on chronic of a significant reduction of the f-helper/inducer subset. The
hemodialysis and normal controls unusual finding of a normal number of T-suppressor/cytotoxic
Percentage inhibition of homologous PHA cells in the presence of marked depletion of total lymphocytes
lymphocyte transformation might suggest that the relative predominance of these cells
could upset the regulatory balance in the immune homeostaticConcanavalin
mechanisms and account for the anergy in uremia. However,
30 g/ Sodium Immune the certainty of this interpretation tends to be diminished by the
Patient no. 5 jig/mI ml periodate complex finding of a low Con A induced suppressor activity in these
—39 ND ND ND patients. This significantly low level of Con A-induced suppres-
2 6 51 24 12 sion is similar to that described in auto-immune diseases [15]
3 97 99 99 66 but contrasts with previous reports of augmented suppressor4 —3 ND —3.6 ND function in uremia using other experimental techniques [13, 14]
6 ND ND ND ND which, however, are less reproducible 115].
7 58 86 68 95 The consistently smaller OKT1 population as compared to
8 ND ND ND ND E-rosettes was not totally unexpected, as the technique of
9 ND ND ND ND fluorescence microscopy used here, is known to give lower
ii 79 ND ND ND results than that obtained using flow cytometric analysis. In
12 43 ND 87 ND addition, it is possible that all E-rosette forming cells are not T-
13 99 ND ND ND cells [30] and all mature T-cells do not express the specific
14 I ND 2 —14 antigen detected by the OKT3 antibody. The sum of the OKT4
and OKT5 cells was frequently greater than the total number
17 86 ND ND ND of OKT cells. This may suggest that the OKT1 antibody is
18 ND ND ND ND underestimating the total T-cell population or that there is a
19 ND ND ND ND population of cells that has both these antigens. A group of
double-marker cells, in fact, has been demonstrated recently in
All patients 36 12b 7t) 16 33 16 36 17 . . -
myasthenia gravis where they were interpreted as being imma-
Controls 67 7 81 7 54 32 34 44 ture cells [31].
The lack of correlation between the numerical and functional
Probability < 0.002 > 0.10 <0.10 > 0.10 assays among both controls and patients suggest that one is
value
-
measuring different indicators of the suppressor population.
These discrepancies may be explained by the fact that one
DPM mitogen-stimulated cells cannot separate the cytotoxic and suppressor aspects of T-cellsa % Suppression = (I — . ) x 100
z DPM non-stimulated cells using OKT8 antibody. The normal number of OKT8 cells may
indicate an adequate supply and function of suppressor T-cells,
DPM — DPM of mitogen stimulated cells DPM of cells without with the latter, however, not being reflected in the Con A test.
mitogen. Alternatively impaired suppression in uremic patients, in fact,Mean — SEM. may be paralleled by a decrease in number of suppressor cells,
but this is not reflected by the enumeration of OKT8 cells
were expressed as a percentage of 0KT3 cells, no difference because of a complementary increase in cytotoxic T-cells. The
was found. The absolute number of OKT5 cells was not dissociation between marker and functional assays which we
significantly different from normals. However, the mean per- have shown here and elsewhere 1151 has also emerged from
centage of OKT8 cells was slightly higher in the patients than recent reports [32] using the same monoclonal antibodies used
in controls (P> 0.05, <0.10). The results expressed as the ratio in this study. In patients with leprosy, a decrease in both in vivo
of OKT4 cells to OKT8 cells showed no significant deviations and in vitro tests of function attributed to T-helper cells, was
from normal. not accompanied by the expected reduction of 0KT41 cells.
Functional assays of suppression. The results are shown in The generation of suppressor activity by sodium periodate
Table 3. The only significant finding was a lower level of and circulating immune complexes produced extremely van-
suppressor activity in uremic patients as compared to control able results with frequent and unpredictable stimulation, rather
subjects when using the suboptimal dose of Con A (5 g/ml). than suppression of the PHA response (Table 3). The subopti-
Correlations. No significant correlation was found between mal dose of 5 g/m1 Con A in this study was most effective at
any of the numerical assays and the tests of suppressor cell demonstrating the difference between the control and patient
function in both the normal control and uremic groups. Similar- groups.
ly, no significant correlations were detected between any of the As the majority of patients tested by us were reasonably
biochemical parameters estimated (Table 4) and the immuno- nourished, malnutrition cannot be implicated as a cause of the
logical tests performed. anergy in uremia.
In evaluating the above findings greater reliance has to be
Discussion placed on the numerical assays using monoclonal antibodies
The reduction in the total circulating lymphocytes, and T- which give simple and reliable results rather than the functional
and B-cell populations confirms previous reports in uremia [6, assays which are subject to technical variations and whose
7]. In keeping with the general cell depletion is the new finding physiological significance is unclear.
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a All results are expressed as the mean SEM and in millimoles per
liter unless otherwise stated.
In conclusion, therefore, the evidence given above on the
numerical imbalance between suppressor and helper T-cells
suggests that altered suppressor cell activity may be a cause of
the immunoparesis in uremia.
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